BridgeMD
New treatment option for Trigger Finger
Official title Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger
ClinicalTrials.gov ID: NCT07256522
What this study is testing
- What it's testing
- Patients aged 18-75 years who present with trigger finger to a tertiary rehabilitation hospital and agree to participate will be included in the study. Participants will be randomly allocated into three groups using block randomization.
- Time commitment: about 3 weeks
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Being between 18 and 75 years of age and willing to participate in the study
- Having a diagnosis of idiopathic single trigger finger, Grade 2-3
You likely can't join if
- Patients with triggering in more than one finger
- Patients with triggering at the A3 pulley or with Grade 1 or Grade 4 trigger finger
- Patients with thumb (pollex) trigger finger
- Patients who have undergone any injection or treatment procedure (release surgery) for trigger finger within the past 6 months
- Patients who have received physical therapy for the hand within the past 6 months
- Patients currently using corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs)
See the full eligibility criteria
- Being between 18 and 75 years of age and willing to participate in the study
- Having a diagnosis of idiopathic single trigger finger, Grade 2-3
- Patients with triggering in more than one finger
- Patients with triggering at the A3 pulley or with Grade 1 or Grade 4 trigger finger
- Patients with thumb (pollex) trigger finger
- Patients who have undergone any injection or treatment procedure (release surgery) for trigger finger within the past 6 months
- Patients who have received physical therapy for the hand within the past 6 months
- Patients currently using corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs)
- Patients with inflammatory or autoimmune rheumatologic diseases such as rheumatoid arthritis, systemic lupus erythematosus, gout, or psoriatic arthritis
- Patients with other musculoskeletal disorders (e.g., carpal tunnel syndrome, de Quervain's tenosynovitis, symptomatic hand osteoarthritis, or Dupuytren's contracture) or neurological diseases (e.g., stroke-related...
- Patients with musculoskeletal disorders causing pain and/or limitation in the proximal upper extremity on the affected side (e.g., periarthritis, lateral epicondylitis, mononeuropathy, or radiculopathy)
- Patients with significant metabolic diseases (e.g., hypothyroidism, Cushing's syndrome, or uncontrolled diabetes)
- Patients with any condition that may interfere with treatment, such as open wounds, rashes, local infections, or active malignant disease of the hand
- Patients with a history of hand trauma (chronic or repetitive)
- Patients unwilling to complete the self-assessment questionnaires either independently or with assistance
- Pregnant women
The study team makes the final eligibility decision.
Where it's taking place
- Konya, Konya, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Konya, Konya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.